DE60103867D1 - Spezielle salzform von triphenylethylenederivaten als selektive östrogenrezeptormodulatoren - Google Patents

Spezielle salzform von triphenylethylenederivaten als selektive östrogenrezeptormodulatoren

Info

Publication number
DE60103867D1
DE60103867D1 DE60103867T DE60103867T DE60103867D1 DE 60103867 D1 DE60103867 D1 DE 60103867D1 DE 60103867 T DE60103867 T DE 60103867T DE 60103867 T DE60103867 T DE 60103867T DE 60103867 D1 DE60103867 D1 DE 60103867D1
Authority
DE
Germany
Prior art keywords
estrogen receptor
receptor modulators
selective estrogen
salt form
special salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60103867T
Other languages
English (en)
Other versions
DE60103867T2 (de
Inventor
Gary A Cain
Reginald O Cann
Christopher A Teleha
Denette K Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of DE60103867D1 publication Critical patent/DE60103867D1/de
Application granted granted Critical
Publication of DE60103867T2 publication Critical patent/DE60103867T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60103867T 2000-04-05 2001-04-05 Spezielle Salzformen von Triphenylethylenderivaten als selektive Östrogenrezeptor-Modulatoren Expired - Lifetime DE60103867T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19458000P 2000-04-05 2000-04-05
US194580P 2000-04-05
PCT/US2001/011169 WO2001077055A2 (en) 2000-04-05 2001-04-05 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators

Publications (2)

Publication Number Publication Date
DE60103867D1 true DE60103867D1 (de) 2004-07-22
DE60103867T2 DE60103867T2 (de) 2005-06-30

Family

ID=22718126

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103867T Expired - Lifetime DE60103867T2 (de) 2000-04-05 2001-04-05 Spezielle Salzformen von Triphenylethylenderivaten als selektive Östrogenrezeptor-Modulatoren

Country Status (12)

Country Link
US (1) US6417394B2 (de)
EP (1) EP1268387B1 (de)
JP (1) JP2004507452A (de)
AT (1) ATE269291T1 (de)
AU (2) AU2001253191B2 (de)
CA (1) CA2403263A1 (de)
DE (1) DE60103867T2 (de)
DK (1) DK1268387T3 (de)
ES (1) ES2222988T3 (de)
PT (1) PT1268387E (de)
TR (1) TR200401601T4 (de)
WO (1) WO2001077055A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004220A3 (cs) 2001-08-11 2004-06-16 Bristol-Myers Squibb Pharma Company Název neuveden
EP1692127B1 (de) * 2003-10-08 2008-07-02 Smithkline Beecham Corporation Triphenylethyleneverbindungen als selektive modulatoren des östrogenrezeptors
US7196119B2 (en) * 2003-10-21 2007-03-27 The Regents Of The University Of California Development of new selective estrogen receptor modulators
US7425580B2 (en) 2004-05-19 2008-09-16 Wyeth (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
CN101484000A (zh) * 2005-11-22 2009-07-15 史密丝克莱恩比彻姆公司 化合物
WO2009120999A2 (en) * 2008-03-28 2009-10-01 Olema Pharmaceuticals, Inc. Use of an endoxifen prodrug for treatment of breast cancer
CN117736134A (zh) * 2012-01-12 2024-03-22 耶鲁大学 通过e3泛素连接酶增强靶蛋白质及其他多肽降解的化合物和方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9208511D0 (en) * 1991-05-09 1992-06-03 Ici Plc Compounds
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
CA2301032C (en) * 1997-08-15 2009-01-13 Duke University A method of preventing or treating estrogen-dependent diseases and disorders

Also Published As

Publication number Publication date
AU2001253191B2 (en) 2006-03-02
PT1268387E (pt) 2004-09-30
EP1268387B1 (de) 2004-06-16
DK1268387T3 (da) 2004-10-18
TR200401601T4 (tr) 2004-08-23
JP2004507452A (ja) 2004-03-11
US20020004496A1 (en) 2002-01-10
US6417394B2 (en) 2002-07-09
ES2222988T3 (es) 2005-02-16
EP1268387A2 (de) 2003-01-02
DE60103867T2 (de) 2005-06-30
CA2403263A1 (en) 2001-10-18
ATE269291T1 (de) 2004-07-15
WO2001077055A3 (en) 2002-05-30
WO2001077055A2 (en) 2001-10-18
AU5319101A (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DK1353672T3 (da) Syntese af 4-amino-thalidomidenantiomerer
NO990066D0 (no) Apoptose-induserende adamantylderivater og deres anvendelse som anticancer-midler
DE69929345D1 (de) Subtituierte isoxazole derivate als estrogen rezeptor modulatore
HK1052500A1 (en) Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
NO20031687D0 (no) Veksthormonsekretagoger
AU5467799A (en) Estrogen receptor modulators
MXPA03001982A (es) Amino-aza-cicloalcanos sustituidos utiles contra la malaria.
IL153406A0 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
WO2003016270A3 (en) Selective estrogen receptor modulators
DK1124842T3 (da) Betulinsyrederivater anvendelige til behandling af neuroektodermale tumorer
MXPA02009773A (es) Derivados de indolin-2-ona y su uso como ligandos de receptores de ocitocina.
ME00428B (me) 5-hlor0-3-(4-metansulfonilfenil)-6'-metil-(2,3')bipiridinil u čistom kristalnom obliku i postupak sinteza
DE60103867D1 (de) Spezielle salzform von triphenylethylenederivaten als selektive östrogenrezeptormodulatoren
MEP23008A (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
MXPA01008347A (es) Compuestos quimicos.
DE602006005254D1 (de) Neue chinolinverbindungen, die dazu in der lage sind, sich an den cb2-rezeptor zu binden
DE60105785D1 (de) Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren
AP2002002641A0 (en) Estrogen agonist metabolites.
RS56004A (en) Triazolo-quinolin derivatives useful as adenosine receptor ligands
GB0425548D0 (en) Radiolabelled ligands
SG85165A1 (en) Alpha, beta-unsaturated ketones
Hayashi et al. Synthesis and evaluation of novel heterocyclic MMP inhibitors
ATE257831T1 (de) Synthese von wasserlöslischem 9-dihydroplacitaxel derivate aus 9-dihydro-13-acetylbacchatin iii
WO2002038534A3 (en) Substituted alkyldiamines as inhibitors of plasmepsin or related proteases
DK1373218T3 (da) Imidazolylderivater til anvendelse som histamin H3-receptorligander

Legal Events

Date Code Title Description
8364 No opposition during term of opposition